Thermo Fisher Scientific Inc at Bank of America Merrill Lynch Health Care Conference Transcript
I think we'll get started. Hi, everyone. My name is Mike Ryskin. I'm from the life science tools and diagnostics team here at Bank of America Merrill Lynch. I want to welcome you to our health care conference. I'm here on behalf of Derik De Bruin, the senior analyst on the team. Unfortunately, he couldn't make it today. He's recovering from a recent surgery, but he's in New York and he's following the presentation on webcast. And believe me, he would be here if he could.
So here to start, we have Marc Casper, CEO of Thermo Fisher Scientific. Thank you for joining us, Marc. The format of the session will be a fireside chat, and then towards the end, I'll open it up to Q&A from the audience.
Questions & Answers
So to begin, I thought maybe we could just start with a quick overview of your first quarter results that you announced a few weeks ago. Certainly very robust on the top line,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |